IRadimed Corporation achieves record Q4 2024 revenue, driven by IV pump demand and monitor sales focus. Learn about their growth strategy & 2025 outlook.

Reducing intravenous (IV) isatuximab delivery from 75 minutes to 30 minutes could provide a wealth of benefits to patients ...

Reports Q4 revenue $19.4M vs $17.5M last year. “We are proud to close out 2024 with another record-breaking quarter, marking our fourteenth ...

A full-time nurse, Ashley Emerson, first learned about infusion therapy on a trip to Arizona a few years back. The vitamin ...

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

On January 22, 2025, the Lions Club of Penetanguishene presented a cheque for $5,200 to Victoria Evans, community Giving ...